Journal Management System
 
Home  |   Add your Journal  |   Features  |   Journal List
Author Login | Reviewer Login | Editor Login
Search  

Medical Archives
Periodical of AVICENA, d.o.o., Sarajevo
Journal Home Page
ISSN: 0350-199X (Print)
ISSN: 1986-5961 (Online)
Language: [ English ]  
News / Announcements

  » Volume 68, Issue 6
      pp. 372-4135
  » Volume 68, Issue 5
      pp. 300-363
  » Volume 68, Issue 4
      pp. 228-293
  » Volume 68, Issue 3
      pp. 156-222
  » Volume 68, Issue 2
      pp. 76-146
  » Volume 68, Issue 1
      pp. 4-70

 

Open Access

Original Research



Chronic Airflow Obstruction Syndrome Due to Pulmonary Tuberculosis Treated with Directly Observed Therapy – a Serious Changes in Lung Function

Milan Radovic, Lidija Ristic, Ivana Stankovic, Tatjana Pejcic, Milan Rancic, Zorica Ciric, Violeta Dinic-Radovic.

Cited by (1)

Abstract
The origin of Chronic airflow obstruction (CAO) syndrome in active Tuberculosis (TB), despite significant similarities with chronic obstructive pulmonary disease (COPD), still remains unknown. The aim of the study was to examine the potential causes and risks for the development of CAO syndrome in new cases of pulmonary TB. Design: Prospective, nest case-control study. Patients: 40 patients with newly detected cavitary pulmonary TB and initial normal respiratory function, diagnosed and treated according to DOTS strategy. Measurements and results: The average values of Snider’s radiological score during TB treatment were significantly reduced (p<0.001), as well as average values ​​of non-specific systemic serum markers of inflammation. The average values ​​of FEV1(%), both before, during and at the end of completion of TB treatment were significantly decreased (p<0.05;). Linear regression analysis confirmed a statistically significant association between changes in the values of FEV1(%), resulting in TB treatment completion, and the value of Snider’s radiological score and the sputum culture conversion rate. From the initial findings of normal pulmonary ventilation tests, upon the completion of TB treatment 35.0% of observed patients developed the CAO syndrome. Logistic regression analysis confirmed a positive familiar burden for COPD, Snider’s radiological score at the beginning of TB treatment and sputum conversion rate on culture, as statistically significant predictors, while multivariate logistic regression analysis confirmed Snider’s radiological score at the beginning of TB treatment and sputum conversion rate on culture as most significant risk factors for CAO syndrome occurrence and development. Conclusion: The CAO syndrome is often a consequence and significant functional impairment of the respiratory system, during the reparative processes in active TB, even in the absence of risk factors for COPD. Only microbiological cure of TB patients with underlying risks for disorders of lung function, is not sufficient and effective approach for prevention of their further potential health deterioration.

Key words: tuberculosis, bronchial obstruction, risk factors, COPD.



REFERENCES
1. Chakrabarti B, Calverley PMA, Davies P. Tuberculosis and its incidence, special nature and relationship with chronic obstructive pulmonary disease. International Journal of COPD. 2007: 2(3) 263-272.
[Pubmed]    [PMC Free Fulltext]   

2. Malik S. Pulmonary tuberculosis and chronic (generalized) airways obstruction. Ind J Tub. 2006; 24: 26-29.


3. Smelev EI, Kuklina GM, Kalinina EE. Treatment of bronchial obstruction in patients with pulmonary tuberculosis. Probl Tuberk Bolezn Legk. 2004; 8: 57-61.
[
Pubmed]   

4. Stručno metodološko uputstvo za sprečavanje i suzbijanje tuberkuloze u Republici Srbiji. Ministarstvo Zdravlja Republike Srbije, Beograd, Srbija, 2009: 11-20. (in Serbian).


5. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991; 86: 1119-1127.
[
DOI via Crossref]   

6. Lee JH, Chang JH. Lung function in patients with chronic airflow obstruction due to tuberculosis destroyed lung. Respir Med. 2003; 97: 1237-1242.
[
DOI via Crossref]   

7. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000; 55: 32-38.
[
DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   

8. Kolappan C, Gopi PG. Tobacco smoking and pulmonary tuberculosis. Thorax. 2002; 57: 964-966.
[
DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   

9. Janson C, Kunzli N, de Marco R, et al. Changes in active and pasive smoking in the European Community Respiratory Health Survey. Eur Respir J. 2006; 27: 517-524.
[
DOI via Crossref]    [Pubmed]   

10. Den Boon S, Van Lill SWP, Borgdorff MW, Verver S, Bateman ED, Lombard CJ, Enarson DA, Beyers N. Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area. Thorax. 2005; 60: 555-557.
[
DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   

11. Lopez AD, Schibua K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006; 27: 397-412.
[
DOI via Crossref]    [Pubmed]   

12. Menezes AMB, Hallal PC, Perez-Padilla R, et al. (for the Latin American Project for the Investigation of Obstructive Lung Disease (PLATINO) Team). Tuberculosis and airflow obstruction:evidence from the PLATINO study in Latin America. Eur Respir J. 2007; 30: 1180-1185.
[
DOI via Crossref]    [Pubmed]   

13. Radha TG, Viswanaihan R. Chronic bronchitis and tuberculosis. Ind J Tub 2006; 24: 3-8.


14. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, Drewyer G, Weis SE. Pulmonary impairment after tuberculosis. Chest. 2007; 131(6): 1817-24.
[
DOI via Crossref]    [Pubmed]   

15. Miller MR. Pedersen OF, Pellegrino R, Brusaco V. Debating the definition of airflow obstruction:time to move on? Eur Respir J. 2010; 34: 527-529.
[
DOI via Crossref]    [Pubmed]   

This Article Cited By the following articles

Risk factors shared by COPD and lung cancer and mediation effect of COPD: two center case–control studies
Cancer Causes Control 2014; (): .

1
 

How to Cite this Article
Pubmed Style

Radovic M, Ristic L, Stankovic I, Pejcic T, Rancic M, Ciric Z, Dinic-Radovic V. Chronic Airflow Obstruction Syndrome Due to Pulmonary Tuberculosis Treated with Directly Observed Therapy – a Serious Changes in Lung Function. Med Arh. 2011; 65(5): 265-269. doi:10.5455/medarh.2011.65.265-



Web Style

Radovic M, Ristic L, Stankovic I, Pejcic T, Rancic M, Ciric Z, Dinic-Radovic V. Chronic Airflow Obstruction Syndrome Due to Pulmonary Tuberculosis Treated with Directly Observed Therapy – a Serious Changes in Lung Function. www.scopemed.org/?mno=12161 [Access: December 20, 2014]. doi:10.5455/medarh.2011.65.265-



AMA (American Medical Association) Style

Radovic M, Ristic L, Stankovic I, Pejcic T, Rancic M, Ciric Z, Dinic-Radovic V. Chronic Airflow Obstruction Syndrome Due to Pulmonary Tuberculosis Treated with Directly Observed Therapy – a Serious Changes in Lung Function. Med Arh. 2011; 65(5): 265-269. doi:10.5455/medarh.2011.65.265-



Vancouver/ICMJE Style

Radovic M, Ristic L, Stankovic I, Pejcic T, Rancic M, Ciric Z, Dinic-Radovic V. Chronic Airflow Obstruction Syndrome Due to Pulmonary Tuberculosis Treated with Directly Observed Therapy – a Serious Changes in Lung Function. Med Arh. (2011), [cited December 20, 2014]; 65(5): 265-269. doi:10.5455/medarh.2011.65.265-



Harvard Style

Radovic, M., Ristic, L., Stankovic, I., Pejcic, T., Rancic, M., Ciric, Z. & Dinic-Radovic, V. (2011) Chronic Airflow Obstruction Syndrome Due to Pulmonary Tuberculosis Treated with Directly Observed Therapy – a Serious Changes in Lung Function. Med Arh, 65 (5), 265-269. doi:10.5455/medarh.2011.65.265-



Turabian Style

Radovic, Milan, Lidija Ristic, Ivana Stankovic, Tatjana Pejcic, Milan Rancic, Zorica Ciric, and Violeta Dinic-Radovic. 2011. Chronic Airflow Obstruction Syndrome Due to Pulmonary Tuberculosis Treated with Directly Observed Therapy – a Serious Changes in Lung Function. Medical Archives, 65 (5), 265-269. doi:10.5455/medarh.2011.65.265-



Chicago Style

Radovic, Milan, Lidija Ristic, Ivana Stankovic, Tatjana Pejcic, Milan Rancic, Zorica Ciric, and Violeta Dinic-Radovic. "Chronic Airflow Obstruction Syndrome Due to Pulmonary Tuberculosis Treated with Directly Observed Therapy – a Serious Changes in Lung Function." Medical Archives 65 (2011), 265-269. doi:10.5455/medarh.2011.65.265-



MLA (The Modern Language Association) Style

Radovic, Milan, Lidija Ristic, Ivana Stankovic, Tatjana Pejcic, Milan Rancic, Zorica Ciric, and Violeta Dinic-Radovic. "Chronic Airflow Obstruction Syndrome Due to Pulmonary Tuberculosis Treated with Directly Observed Therapy – a Serious Changes in Lung Function." Medical Archives 65.5 (2011), 265-269. Print. doi:10.5455/medarh.2011.65.265-



APA (American Psychological Association) Style

Radovic, M., Ristic, L., Stankovic, I., Pejcic, T., Rancic, M., Ciric, Z. & Dinic-Radovic, V. (2011) Chronic Airflow Obstruction Syndrome Due to Pulmonary Tuberculosis Treated with Directly Observed Therapy – a Serious Changes in Lung Function. Medical Archives, 65 (5), 265-269. doi:10.5455/medarh.2011.65.265-



Submit your manuscript
Register
Abstracting & Indexing
Instructions for Authors
Editorial Board
Aims & Scope
About this Journal
Sign up for TOC

ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Milan Radovic
Articles by Lidija Ristic
Articles by Ivana Stankovic
Articles by Tatjana Pejcic
Articles by Milan Rancic
Articles by Zorica Ciric
Articles by Violeta Dinic-Radovic
on IndexScholar Fulltext
on Google
on Google Scholar
Article Statistics
 Viewed: 2467
Downloaded: 550
Cited: 1




 




» For Authors




Become Reviewer


» Login Area






Follow ScopeMed on Twitter

ScopeMed Home
Job Opportunities/Service Offers
About ScopeMed
Terms & Conditions
Privacy Policy
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of SAGEYA Publishing for Scientific Publications. Copyright © ScopeMed® International Medical Journal Management and Indexing System.